REPL Replimune Group, Inc.

BEARISH Impact: 4/10 Institutional Cluster
Horizon weeks Processed 2d 4h ago
Institutional cluster: 4 buyers, 2 sellers (mixed)

Executive Summary

In Q3 2025, four mega-passive institutions (Fidelity, Morgan Stanley, Invesco, UBS) increased their REPL holdings by a net $320K, while two sellers (Citadel and BofA) reduced by $6.3M. The cluster is dominated by passive rebalancing, not active conviction, and the net selling pressure outweighs buying, suggesting no strong shared bullish thesis.

Key Financial Metrics

Direction
distributing
Buy Value
$15.9M
Sell Value
$7.3M
Net Flow
-$6.0M

Institutional Positions

Net institutional flow: -$6.0M

▲ Buyers (4)

InstitutionActionChangePosition ValueValue Δ
Fidelity DOUBLED +247.5% $5.7M $2.1M
Morgan Stanley ADD +49.2% $5.8M -$2.8M
Invesco ADD +29.3% $647.0K -$462.0K
UBS DOUBLED +270.4% $3.8M $1.5M

▼ Sellers (2)

InstitutionActionChangePrev ValueValue Δ
Citadel TRIM -56.7% $2.6M -$2.1M
BofA NEAR_EXIT -78.4% $4.7M -$4.2M

Actionable Insight

The cluster shows no active-manager buying conviction; passive rebalancing dominates the buy side while a quant and a passive manager both sold heavily. Monitor for further insider selling (7 sells in 30d) and any catalyst-driven reversal. The net negative institutional flow suggests caution.

Key Facts

  • 4 buyers added $15.9M in current holdings, net change +$320K
  • 2 sellers reduced by $6.3M, led by BofA near-exit (-$4.2M) and Citadel trim (-$2.1M)
  • All buyers are mega-passive/index funds (Fidelity, Morgan Stanley, Invesco, UBS) — low signal conviction
  • Sellers include a quant fund (Citadel) and a passive manager (BofA), both reducing significantly
  • Net institutional flow is negative: sellers removed $6.3M vs buyers added only $320K

Financial Impact

Net institutional selling of approximately $6.0M (sellers $6.3M minus buyers $0.32M)

institutional ownershipfloat

Risk Factors

  • Passive buying may reverse if index rebalancing ends
  • Insider selling pattern (7 sells in 30d) aligns with institutional distribution
  • Low analyst bullishness (8% buy rating) and small market cap ($699M) increase volatility

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
8% bullish (13 analysts)

Documents Analyzed

This report is based on 1 institutional 13F filing from SEC EDGAR.

DocumentAccession Number
INST-CLUSTER Data (Synthetic)inst-cluster-REPL-2025-Q3
6 reports for REPL
Performance horizon
100% Hit rate 4 of 4 directional calls best @ T+5▲ +14.84%May 29, 2026
Filters
Rows
Reports for REPL — sortable, filterable
Type Now
Jun 11, 2026
2d ago
Institutional Cluster
BEARISH ★ 4/10
$8.46 awaiting T+5awaiting T+5
May 31, 2026
13d ago
Press Release
BULLISH ★ 6/10
$9.00 $9.47▲ +5.22%▲ +7.97%
May 30, 2026
14d ago
Press Release
BULLISH ★ 8/10
$9.00 $9.47▲ +5.22%▲ +7.97%
May 29, 2026
15d ago
8-K
BULLISH ★ 7/10
$8.69 $9.98▲ +14.84%▲ +15.14%
May 29, 2026
15d ago
Press Release
BULLISH ★ 8/10
$8.69 $9.98▲ +14.84%▲ +15.14%
May 20, 2026
23d ago
Insider Cluster
NEUTRAL ★ 4/10
$5.22 $8.69▲ +66.48%▲ +64.63%
Showing 6 of 6

US Market Status

Market Closed — Opens Mon (44h 5m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access